Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Clinical Utility of Ultrasensitive ctDNA Detection Across the Renal Cell Carcinoma Disease Spectrum: A Multi-Cohort Retrospective Study.

In a single-center retrospective study using NeXT Personal Dx, ctDNA cleared after nephrectomy in the 3-patient perioperative group, 8 of 25 surveillance patients were positive, all 5 who progressed on imaging were positive, and none of 17 ctDNA-negative surveillance patients progressed.

Kidney Cancer Research Summit (KCRS26) 2026